Jefferies Reiterates Buy on Magellan Health (MGLN) Following 4Q - PT to $77
Jefferies reiterated a Buy rating on Magellan Health Services (NASDAQ: MGLN), and raised the price target to $77.00 (from $73.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
